Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

15.38
-0.9200-5.64%
Post-market: 15.500.1200+0.78%19:59 EDT
Volume:3.28M
Turnover:49.55M
Market Cap:958.05M
PE:-4.44
High:16.36
Open:16.29
Low:13.21
Close:16.30
52wk High:71.50
52wk Low:8.42
Shares:62.29M
Float Shares:40.64M
Volume Ratio:2.82
T/O Rate:8.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4602
EPS(LYR):-3.4602
ROE:-207.10%
ROA:-16.21%
PB:4.82
PE(LYR):-4.44

Loading ...

uniQure posts FY 2025 net loss of USD 199.0 million, down 17%

Reuters
·
Mar 02

Press Release: uniQure Announces 2025 Financial Results and Provides Recent Company Updates

Dow Jones
·
Mar 02

FDA rejects uniQure AMT-130 Phase I/II data as sufficient for approval filing

Reuters
·
Mar 02

uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

GlobeNewswire
·
Mar 02

Uniqure NV expected to post a loss of 95 cents a share - Earnings Preview

Reuters
·
Feb 27

RBC Capital says Makary comments on uniQure gene therapy approach disappointing

TIPRANKS
·
Feb 27

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and uniQure (QURE)

TIPRANKS
·
Feb 27

Stifel says uniQure ‘understandably’ under pressure on Makary comments

TIPRANKS
·
Feb 27

Class Action Lawsuit Targets uniQure NV Investors

Reuters
·
Feb 26

Rosen Law Firm Sets April 13 Lead Plaintiff Deadline in uniQure Securities Class Action

Reuters
·
Feb 26

Rosen Law Firm urges uniQure investors to act before April 13 lead plaintiff deadline

Reuters
·
Feb 25

uniQure Initiated at Peer Perform by Wolfe Research

Dow Jones
·
Feb 24

uniQure initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
Feb 24

uniQure NV updated its financial calendar

Reuters
·
Feb 23

uniQure to Announce 2025 Financial Results

GlobeNewswire
·
Feb 23

Class Action Lawsuit Targets uniQure NV Over Alleged Securities Fraud

Reuters
·
Feb 18

Investors Sue uniQure NV Over Alleged Misleading Disclosures

Reuters
·
Feb 17

uniQure Faces Class Action Over Alleged Misleading Statements on Drug Approval

Reuters
·
Feb 14

Assessing uniQure (QURE) Valuation After New Securities Fraud Lawsuit On AMT-130 Disclosures

Simply Wall St.
·
Feb 12

uniQure Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 10